Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00005035What this trial is testingOxaliplatin in Treating Patients With Advanced Head and Neck CancerWho this might be right forHead and Neck Cancer Ohio State University Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01249547What this trial is testingNasopharyngeal Carcinoma (NPC) AxitinibWho this might be right forRecurrent or Metastatic NPC Chinese University of Hong Kong 37
Early research (Phase 1)Study completedNCT00717184What this trial is testingA Pilot Study of Autologous Ex Vivo Activated NK Cell Infusion in the Treatment of Metastatic Nasopharyngeal CarcinomaWho this might be right forMetastatic Nasopharyngeal National University Hospital, Singapore
Large-scale testing (Phase 3)Looking for participantsNCT07188584What this trial is testingPhase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal CancerWho this might be right forNasopharyngeal Carcinoma (NPC) Ming-Yuan Chen 166
Testing effectiveness (Phase 2)Study completedNCT03007836What this trial is testingHigh-activity Natural Killer Immunotherapy for Small Metastases of Nasopharyngeal CancerWho this might be right forMetastatic Nasopharyngeal Cancer Fuda Cancer Hospital, Guangzhou 20
Not applicableEnded earlyNCT00898430What this trial is testingBiomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation TherapyWho this might be right forHead and Neck Cancer Vanderbilt-Ingram Cancer Center 49
Large-scale testing (Phase 3)Looking for participantsNCT06241599What this trial is testingA Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)Who this might be right forRecurrent or Metastatic Nasopharyngeal Carcinoma Sun Yat-sen University 300
Testing effectiveness (Phase 2)Study completedNCT00003582What this trial is testingRadiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck CancerWho this might be right forCarcinoma of Unknown PrimaryHead and Neck Cancer University of Miami 36
Testing effectiveness (Phase 2)Study completedNCT00098631What this trial is testingLapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult PrimaryRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Squamous Cell Carcinoma of the Hypopharynx+13 more National Cancer Institute (NCI) 88
Testing effectiveness (Phase 2)Study completedNCT04509726What this trial is testingEBV Specific Cytokine Secreting TCR-T Cells in the Treatment of EBV-Positive Metastatic/Refractory Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Carcinoma Xinqiao Hospital of Chongqing 9
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Study completedNCT03180476What this trial is testingMaintenance Therapy of Apatinib After Chemoradiotherapy in Metastatic Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Neoplasms Sichuan Cancer Hospital and Research Institute 21
Not applicableStudy completedNCT00899821What this trial is testingMicrosphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck CancerWho this might be right forHead and Neck Cancer NYU Langone Health
Large-scale testing (Phase 3)Active Not RecruitingNCT06118333What this trial is testingA Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma(PANKU-NPC01)Who this might be right forNasopharyngeal Carcinoma Sichuan Baili Pharmaceutical Co., Ltd. 386
Not applicableNot Yet RecruitingNCT07578727What this trial is testingA Multicenter, Prospective, Phase III Clinical Study of Proton Intensity-modulated Radiotherapy Versus Photon Intensity-modulated Radiotherapy for Untreated Non-metastatic Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Carcinoma (NPC) Guangzhou Concord Cancer Center 504
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06892431What this trial is testingJMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal CancerWho this might be right forRecurrent or Metastatic Nasopharyngeal CancerPatients Who Have Experienced Treatment Failure at Least Second-line Chemotherapy Shanghai JMT-Bio Inc. 150
Testing effectiveness (Phase 2)Study completedNCT01094405What this trial is testingEfficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional TherapyWho this might be right forNasopharyngeal CancerEpstein-Barr Virus Infections Chinese University of Hong Kong 25
Testing effectiveness (Phase 2)UnknownNCT00003856What this trial is testingPhotodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation TherapyWho this might be right forHead and Neck Cancer Quintiles, Inc. 75
Testing effectiveness (Phase 2)Study completedNCT01469429What this trial is testingPhase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.Who this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaSalivary Gland Squamous Cell CarcinomaStage 0 Hypopharyngeal Cancer+55 more Ohio State University Comprehensive Cancer Center 70